SPY305.95+0.40 0.13%
DIA256.50+1.23 0.48%
IXIC9,507.54-44.51 -0.47%

Guggenheim Initiates Coverage On Health Catalyst with Buy Rating, Announces Price Target of $33

Guggenheim initiates coverage on Health Catalyst (NASDAQ:HCAT) with a Buy rating and announces Price Target of $33.

Benzinga · 05/15/2020 11:08

Guggenheim initiates coverage on Health Catalyst (NASDAQ:HCAT) with a Buy rating and announces Price Target of $33.